Director Galanski receives 1,594 AXIS Capital (AXS) shares as fees
Rhea-AI Filing Summary
AXIS Capital Holdings Ltd director Stanley A. Galanski reported receiving 1,594 common shares of AXS on January 15, 2026. The Form 4 classifies this as an acquisition of non-derivative securities, bringing his directly held stake to 15,022 common shares after the transaction.
According to the footnote, these shares were issued as director’s fees, using the January 15, 2026 closing share price of $100.34 to determine the value, indicating a stock-based compensation grant rather than an open-market purchase.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did AXIS Capital (AXS) report in this Form 4?
The Form 4 reports that director Stanley A. Galanski acquired 1,594 AXIS Capital common shares on January 15, 2026 as a stock-based compensation grant.
Is the AXIS Capital (AXS) director transaction a purchase or compensation grant?
The filing states the 1,594 common shares were issued as director's fees, meaning this was equity compensation rather than an open-market share purchase.
What is Stanley A. Galanski’s AXIS Capital (AXS) shareholding after this Form 4?
After receiving the director fee grant, Stanley A. Galanski directly beneficially owns 15,022 AXIS Capital common shares, as reported in the filing.
What price was used to value the AXIS Capital (AXS) director fee shares?
The footnote explains that the 1,594 common shares issued as director’s fees were valued using the January 15, 2026 closing price of $100.34 per share.
Does the AXIS Capital (AXS) Form 4 involve derivative securities?
No. The reported transaction involves non-derivative common shares only, and the table for derivative securities shows no derivative positions acquired or disposed of.
What is the relationship of the reporting person to AXIS Capital (AXS)?
The reporting person, Stanley A. Galanski, is identified in the filing as a director of AXIS Capital Holdings Ltd and is not listed as a 10% owner or officer.